A citation-based method for searching scientific literature

G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
Times Cited: 248







List of co-cited articles
1424 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
47

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
256
40

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
206
34

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
33

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
592
33

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
30

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
744
29

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
98
27

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
449
26

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
26

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
233
26

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
151
25

Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Marjorie A Ariano, Carlos Cepeda, Christopher R Calvert, Jorge Flores-Hernández, Elizabeth Hernández-Echeagaray, Gloria J Klapstein, Scott H Chandler, Neil Aronin, Marian DiFiglia, Michael S Levine. J Neurophysiol 2005
82
29


Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
341
23

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.
Austen J Milnerwood, Clare M Gladding, Mahmoud A Pouladi, Alexandra M Kaufman, Rochelle M Hines, Jamie D Boyd, Rebecca W Y Ko, Oana C Vasuta, Rona K Graham, Michael R Hayden,[...]. Neuron 2010
349
23

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
82
26

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
242
22



A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
637
19

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.
Carlos Cepeda, Damian M Cummings, Véronique M André, Sandra M Holley, Michael S Levine. ASN Neuro 2010
61
31

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
G A Laforet, E Sapp, K Chase, C McIntyre, F M Boyce, M Campbell, B A Cadigan, L Warzecki, D A Tagle, P H Reddy,[...]. J Neurosci 2001
205
19

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
123
18

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
262
18




Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
Mahmoud A Pouladi, Lisa M Stanek, Yuanyun Xie, Sonia Franciosi, Amber L Southwell, Yu Deng, Stefanie Butland, Weining Zhang, Seng H Cheng, Lamya S Shihabuddin,[...]. Hum Mol Genet 2012
106
16

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
16

Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice.
Xiaoping Tong, Yan Ao, Guido C Faas, Sinifunanya E Nwaobi, Ji Xu, Martin D Haustein, Mark A Anderson, Istvan Mody, Michelle L Olsen, Michael V Sofroniew,[...]. Nat Neurosci 2014
342
16

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
Carlos Cepeda, Amaal J Starling, Nanping Wu, Oanh K Nguyen, Besim Uzgil, Takahiro Soda, Veronique M André, Marjorie A Ariano, Michael S Levine. J Neurosci Res 2004
102
16

Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
124
16

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
Michael S Levine, Carlos Cepeda, Miriam A Hickey, Sheila M Fleming, Marie-Françoise Chesselet. Trends Neurosci 2004
127
16

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
945
15


Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.
M S Levine, G J Klapstein, A Koppel, E Gruen, C Cepeda, M E Vargas, E S Jokel, E M Carpenter, H Zanjani, R S Hurst,[...]. J Neurosci Res 1999
258
15

Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
Tara L Spires, Helen E Grote, Sylvia Garry, Patricia M Cordery, Anton Van Dellen, Colin Blakemore, Anthony J Hannan. Eur J Neurosci 2004
141
15

Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.
Damian M Cummings, Austen J Milnerwood, Glenn M Dallérac, Verina Waights, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Kerry P S J Murphy. Hum Mol Genet 2006
88
17

Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Jeremy M Van Raamsdonk, Jacqueline Pearson, Elizabeth J Slow, Sazzad M Hossain, Blair R Leavitt, Michael R Hayden. J Neurosci 2005
232
14

Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease.
Renata P Lerner, Luz Del Carmen G Trejo Martinez, Chunni Zhu, Marie-Françoise Chesselet, Miriam A Hickey. Brain Res Bull 2012
38
36

Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.
Benjamin R Miller, Adam G Walker, Anand S Shah, Scott J Barton, George V Rebec. J Neurophysiol 2008
88
15

Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
Nan Wang, Michelle Gray, Xiao-Hong Lu, Jeffrey P Cantle, Sandra M Holley, Erin Greiner, Xiaofeng Gu, Dyna Shirasaki, Carlos Cepeda, Yuqing Li,[...]. Nat Med 2014
138
14


Choosing an animal model for the study of Huntington's disease.
Mahmoud A Pouladi, A Jennifer Morton, Michael R Hayden. Nat Rev Neurosci 2013
214
13

Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
Rona K Graham, Mahmoud A Pouladi, Prasad Joshi, Ge Lu, Yu Deng, Nan-Ping Wu, Bryan E Figueroa, Martina Metzler, Véronique M André, Elizabeth J Slow,[...]. J Neurosci 2009
94
13

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
H Diana Rosas, David S Tuch, Nathanael D Hevelone, Alexandra K Zaleta, Mark Vangel, Steven M Hersch, David H Salat. Mov Disord 2006
245
13

Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.
Sonia Marco, Albert Giralt, Milos M Petrovic, Mahmoud A Pouladi, Rebeca Martínez-Turrillas, José Martínez-Hernández, Linda S Kaltenbach, Jesús Torres-Peraza, Rona K Graham, Masahiko Watanabe,[...]. Nat Med 2013
81
16

Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.
Peter Langfelder, Jeffrey P Cantle, Doxa Chatzopoulou, Nan Wang, Fuying Gao, Ismael Al-Ramahi, Xiao-Hong Lu, Eliana Marisa Ramos, Karla El-Zein, Yining Zhao,[...]. Nat Neurosci 2016
203
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.